The GDC is planning Data Release 47 in December 2026, bringing new genomic and clinical datasets to support cancer research. Highlights of the planned release include:
- New whole genome sequencing (WGS) variant calls from diverse projects
- Data from new projects including:
- WGS, whole exome sequencing (WXS), ribonucleic acid sequencing (RNA-Seq), and microRNA sequencing (miRNA-Seq) data from the Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST) screening arm (phs001140)
- WGS, WXS, RNA-Seq, and miRNA-Seq data, and Methylation arrays from the CCG Multicentric Italian Lung Detection (MILD) study (phs002253)
- WXS and RNA-Seq data from the Clinical Trial Sequencing Project (CTSP) Kidney Renal Clear Cell Carcinoma (KIRC) study (phs001893)
- WGS and RNA-Seq alignments from the Molecular Profiling to Predict Response to Treatment (MP2PRT) Endometrial Cancer study (phs002965)
- New data from existing projects:
- scRNA-Seq2 expression matrices from the Refractory Cancers (RC) HOPE-CARE study (phs002098)
- WGS, WXS, RNA-Seq, and miRNA-Seq data, and Methylation arrays from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) sarcoma study (phs001287)
- WXS, RNA-Seq, and miRNA-Seq data from the Human Cancer Models Initiative (HCMI) (phs001486)
- WXS data from the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network Colorectal Cancer Patients in Cancer Genomic Characterization (COPECC) study (phs003985)
- Tumor-only targeted sequencing data from the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) osteosarcoma study (phs000468)
- miRNA-Seq data from the Cancer Genome Atlas (TCGA) Testicular Germ Cell Tumors (TCGT) study (phs000178)
For a complete summary of all GDC Data Releases, see the GDC Data Release Notes.